PT-141 (Bremelanotide)
Melanocortin receptor agonist studied for libido and central arousal pathways.
Recon & Dosing
Open the calculator for PT-141 (Bremelanotide) vials.
- Category
- Cognitive
- Half-life
- ~2.7 hours
- Typical vial
- 10 mg lyophilised
- Reported research dose
- 0.5–2 mg per administration in trial arms
Mechanism of action
MC3R/MC4R agonism acting on hypothalamic arousal circuits.
Storage & handling
Refrigerate reconstituted.
Run the reconstitution math →Research notes
- Transient nausea and flushing are the most commonly reported effects.
Research use only. Figures above summarise published literature and community protocols for reference. Nothing here is a recommendation for human use.